A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
BeOne Medicines
BeOne Medicines
Shanghai Henlius Biotech
Compass Therapeutics
Exelixis
AstraZeneca
Eisai Inc.
Zymeworks BC Inc.
ViroMissile, Inc.
Eisai Inc.
Seagen Inc.
SEED Therapeutics, Inc.
Alnylam Pharmaceuticals
MacroGenics
SAPU NANO (US) LLC
Jiangsu Simcere Pharmaceutical Co., Ltd.
AbbVie
Myeloid Therapeutics
Shanghai JMT-Bio Inc.
Shanghai Ruiliyuan Biotechnology Co., Ltd.
NeoTX Therapeutics Ltd.
AccSalus Biosciences, Inc.
Tyra Biosciences, Inc
Coherus Oncology, Inc.
HiFiBiO Therapeutics
Incyte Corporation
Bayer
Chiome Bioscience Inc.
Eureka Therapeutics Inc.
Incyte Corporation
Pfizer
Exelixis
Incyte Corporation
Incyte Corporation
Captor Therapeutics S.A.
AbbVie
HC Biopharma Inc.
Lion TCR Pte. Ltd.
Bayer
Bristol-Myers Squibb
Aptamer Sciences, Inc.
LaunXP Biomedical Co., Ltd.
Mina Alpha Limited
TORL Biotherapeutics, LLC
AbbVie
Incyte Corporation
Sotio Biotech Inc.
Carisma Therapeutics Inc
Hoffmann-La Roche
TopAlliance Biosciences
GenVivo, Inc.